Stereotaxis, Inc. (STXS)
AMEX · Common · CUSIP 85916J102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for STXS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
85916J102
Market Cap
Small Cap
Business: Stereotaxis, Inc. is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. With over 100 patents for use in a hospital's interventional surgical suite, Stereotaxis helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced collaboration of life-saving information. Stereotaxis' core technologies are the Niobe ES Remote Magnetic Navigation system, the Odyssey portfolio of lab optimization, networking and patient information management systems and the Vdrive Robotic Mechanical Navigation system and consumables.

Company Contact

CEO
David Fischel
CFO
Kimberly Peery
Headquarters
710 North Tucker Boulevard, Suite 110, St. Louis, MO 63101
Phone
314-678-6100 · Toll-Free 866-646-2346
Fax
314-678-6159
Investor Relations
Kimberly Peery · 314-678-6100 · investors@stereotaxis.com
General Email
info@stereotaxis.com
SEC EDGAR Filings
View filings »